In the short term, agreed. Over the longer term, I think enough of this will damage trust in US drugs which I expect to erode demand, while lowering the approval bar, increasing supply. Brands (the only thing left supporting confidence at that point) may also struggle, especially if some of them decide to cash in with questionable drugs for quick profits.
This is how the US increases drug profits. Prices won’t come down.
In the short term, agreed. Over the longer term, I think enough of this will damage trust in US drugs which I expect to erode demand, while lowering the approval bar, increasing supply. Brands (the only thing left supporting confidence at that point) may also struggle, especially if some of them decide to cash in with questionable drugs for quick profits.
Eroding demand = sick people dying without the medicine they need